These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 30619331)

  • 1. How Should We Classify Kawasaki Disease?
    Marrani E; Burns JC; Cimaz R
    Front Immunol; 2018; 9():2974. PubMed ID: 30619331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histopathological aspects of cardiovascular lesions in Kawasaki disease.
    Takahashi K; Oharaseki T; Yokouchi Y
    Int J Rheum Dis; 2018 Jan; 21(1):31-35. PubMed ID: 29105353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoinflammatory diseases with Kawasaki-like onset: A case series.
    Gamalero L; Giani T; Ferrara G; Cimaz R
    Pediatr Int; 2023; 65(1):e15410. PubMed ID: 36326348
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoinflammatory diseases: update on classification diagnosis and management.
    Pathak S; McDermott MF; Savic S
    J Clin Pathol; 2017 Jan; 70(1):1-8. PubMed ID: 27646526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kawasaki Disease: The Role of Immune Complexes Revisited.
    Menikou S; Langford PR; Levin M
    Front Immunol; 2019; 10():1156. PubMed ID: 31263461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kawasaki disease: basic and pathological findings.
    Takahashi K; Oharaseki T; Yokouchi Y; Naoe S; Saji T
    Clin Exp Nephrol; 2013 Oct; 17(5):690-693. PubMed ID: 23188196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on understanding the pathophysiology in Kawasaki disease: Possible role of immune complexes in coronary artery lesion revisited.
    Philip S; Jindal A; Krishna Kumar R
    Int J Rheum Dis; 2023 Aug; 26(8):1453-1463. PubMed ID: 37431726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune Aspects of Kawasaki Disease.
    Sakurai Y
    J Investig Allergol Clin Immunol; 2019; 29(4):251-261. PubMed ID: 30183655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic.
    Koné-Paut I; Cimaz R
    RMD Open; 2020 Jun; 6(2):. PubMed ID: 32611651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The autoinflammatory assault on conventional diagnostic criteria.
    Heymann WR
    Skinmed; 2014; 12(4):240-1. PubMed ID: 25335354
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunogenetics of Kawasaki disease.
    Kumrah R; Vignesh P; Rawat A; Singh S
    Clin Rev Allergy Immunol; 2020 Aug; 59(1):122-139. PubMed ID: 32200494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A framework for understanding Kawasaki disease pathogenesis.
    Lo MS
    Clin Immunol; 2020 May; 214():108385. PubMed ID: 32173601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction to autoinflammatory syndromes and diseases.
    Abramovits W; Oquendo M
    Dermatol Clin; 2013 Jul; 31(3):363-85. PubMed ID: 23827242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kawasaki disease: Shedding light on a mysterious diagnosis.
    Galuppo J; Kowker A; Rolfs J; Nicholas J; Schmidt E
    JAAPA; 2020 Jul; 33(7):18-22. PubMed ID: 32520905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic vasculitis].
    Fain O; Mekinian A
    Rev Prat; 2014 Jan; 64(1):113-26. PubMed ID: 24649563
    [No Abstract]   [Full Text] [Related]  

  • 16. Autoinflammatory syndromes for the dermatologist.
    Dávila-Seijo P; Hernández-Martín A; Torrelo A
    Clin Dermatol; 2014; 32(4):488-501. PubMed ID: 25017460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial immune protein expression demonstrates the complexity of immune responses in Kawasaki disease arteritis.
    Cameron SA; White SM; Arrollo D; Shulman ST; Rowley AH
    Clin Exp Immunol; 2017 Nov; 190(2):244-250. PubMed ID: 28707750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. M1 macrophage is the predominant phenotype in coronary artery lesions following Kawasaki disease.
    Ohashi R; Fukazawa R; Shimizu A; Ogawa S; Ochi M; Nitta T; Itoh Y
    Vasc Med; 2019 Dec; 24(6):484-492. PubMed ID: 31621532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Type I interferonopathies. Systemic inflammatory diseases triggered by type I interferons].
    Günther C; Schmidt F; König N; Lee-Kirsch MA
    Z Rheumatol; 2016 Mar; 75(2):134-40. PubMed ID: 26744186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing coronary artery lesions in Kawasaki disease.
    Kuo HC
    Biomed J; 2017 Jun; 40(3):141-146. PubMed ID: 28651735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.